SULIMAN SHEHNAAZ has filed 8 insider transactions across 2 companies since June 2023.
Most recent transaction: a grant/award of 15357 shares of 10x Genomics, Inc. ($TXG) on June 03, 2025.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| June 3, 2025 | 10x Genomics, Inc. | $TXG | SULIMAN SHEHNAAZ | Not found | A | Class A Common Stock | 15357 | $0.00 | 28,616.0000 | 120,451,550 | 115.82% | 0.01% |
| May 15, 2025 | Ultragenyx Pharmaceutical Inc. | $RARE | SULIMAN SHEHNAAZ | Not found | A | Stock Option (Right to Buy) | 10787 | $0.00 | 10,787.0000 | 90,538,118 | 9999.99% | 0.01% |
| May 15, 2025 | Ultragenyx Pharmaceutical Inc. | $RARE | SULIMAN SHEHNAAZ | Not found | A | Common Stock | 5740 | $0.00 | 25,940.0000 | 90,538,118 | 28.42% | 0.01% |
| June 18, 2024 | Ultragenyx Pharmaceutical Inc. | $RARE | SULIMAN SHEHNAAZ | Not found | A | Stock Option (Right to Buy) | 9900 | $0.00 | 9,900.0000 | 73,543,862 | 9999.99% | 0.01% |
| June 18, 2024 | Ultragenyx Pharmaceutical Inc. | $RARE | SULIMAN SHEHNAAZ | Not found | A | Common Stock | 5345 | $0.00 | 20,200.0000 | 73,543,862 | 35.98% | 0.01% |
| June 11, 2024 | 10x Genomics, Inc. | $TXG | SULIMAN SHEHNAAZ | Not found | A | Class A Common Stock | 8649 | $0.00 | 13,259.0000 | 117,165,036 | 187.61% | 0.01% |
| June 7, 2023 | Ultragenyx Pharmaceutical Inc. | $RARE | SULIMAN SHEHNAAZ | Director | A | Common Stock | 3860 | $0.00 | 14,855.0000 | 69,914,225 | 35.11% | 0.01% |
| June 7, 2023 | Ultragenyx Pharmaceutical Inc. | $RARE | SULIMAN SHEHNAAZ | Director | A | Stock Option (Right to Buy) | 7110 | $0.00 | 7,110.0000 | 69,914,225 | 9999.99% | 0.01% |